What do the new studies say
Understanding how GLP-1 compounds affect hormonal cycles is also relevant for women planning long-term use
They also enhance the bodys ability to utilize insulin effectively, which helps lower blood sugar levels
Zepbound (Nov 2023) is approved for chronic weight management in adults with obesity or overweight plus related conditions, making insurance coverage for weight loss more straightforward
She received advisory/consulting fees and/or other support from: Novo Nordisk, Eli Lilly and Company, Sanofi, AstraZeneca, Boehringer Ingelheim, Janssen, Intercept, Intarcia, Target Pharma, Merck, Pfizer, Novartis, GI Dynamics, Mylan, Mannkind, Valeritas, Zealand Pharma, Shionogi, Carmot and Bayer